Rituximab-induced Elimination of Acquired Angioedema Due to C1-Inhibitor Deficiency Marcel Levi, MD, C. Erik Hack, MD, Marinus H. van Oers, MD The American Journal of Medicine Volume 119, Issue 8, Pages e3-e5 (August 2006) DOI: 10.1016/j.amjmed.2005.09.018 Copyright © 2006 Elsevier Inc. Terms and Conditions
Figure 1 Effect of the administration of anti-CD20 antibodies (indicated with arrows) in 3 patients with acquired C1-inhibitor deficiency (patient A: ▴ and black bars, patient B: ■ and striped bars, patient C: • and white bars) on plasma levels of C1-inhibitor and C4, frequency of serious angioedema attacks (upper airway edema, facial edema, severe edema of extremities or genitals, and severe abdominal attacks) and the monthly requirement for C1-inhibitor concentrate (in units). The American Journal of Medicine 2006 119, e3-e5DOI: (10.1016/j.amjmed.2005.09.018) Copyright © 2006 Elsevier Inc. Terms and Conditions